• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation.

作者信息

Hubscher S G, Elias E, Buckels J A, Mayer A D, McMaster P, Neuberger J M

机构信息

Department of Pathology, Medical School, University of Birmingham, UK.

出版信息

J Hepatol. 1993 Jun;18(2):173-84. doi: 10.1016/s0168-8278(05)80244-2.

DOI:10.1016/s0168-8278(05)80244-2
PMID:8409333
Abstract

Histological evidence of primary biliary cirrhosis (PBC) recurring after orthotopic liver transplantation (OLT) was looked for in a 'blinded' study of 353 biopsies from 188 patients, 12-100 months post-transplant. Biopsies (172) were obtained from 83 patients transplanted for PBC and 181 biopsies from 105 patients with other liver diseases. Sixteen biopsies from 13 PBC patients (16%) had features suggestive of recurrent disease. The main diagnostic findings were: mononuclear portal inflammatory infiltration (n = 16), portal lymphoid aggregates (n = 14), portal epithelioid granulomas (n = 14) and bile duct damage (n = 15). This combination of changes was not seen in any biopsy from the non-PBC group. Additional features supporting a diagnosis of recurrent disease were ductopenia (n = 7), bile ductular proliferation (n = 7), portal fibrosis (n = 6) and copper deposition (n = 5). Thirteen biopsies from 12 patients were classified as stage I or II histologically. The other patient developed progressive damage in three serial biopsies resulting in an early micronodular cirrhosis, 5 years post-transplant. These observations provide further evidence that PBC recurs after OLT. More studies are required to determine the natural history and clinical significance of the predominantly early histological changes documented so far.

摘要

相似文献

1
Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation.
J Hepatol. 1993 Jun;18(2):173-84. doi: 10.1016/s0168-8278(05)80244-2.
2
Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.原发性胆汁性肝硬化肝移植术后疾病复发的免疫组化证据。
Hepatology. 1996 Nov;24(5):1079-84. doi: 10.1002/hep.510240517.
3
Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.100例肝移植后原发性胆汁性肝硬化复发患者的长期随访
Clin Transplant. 2006 Mar-Apr;20(2):211-20. doi: 10.1111/j.1399-0012.2005.00471.x.
4
Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?原发性胆汁性肝硬化中的壁细胞抗体:肝移植后复发的潜在标志物?
Ann Hepatol. 2010 Apr-Jun;9(2):181-5.
5
Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation.
Transplantation. 1998 May 27;65(10):1328-33. doi: 10.1097/00007890-199805270-00008.
6
Bile duct lesions and diminution in number of intrahepatic bile ducts in asymptomatic primary biliary cirrhosis.无症状原发性胆汁性肝硬化患者的胆管病变及肝内胆管数量减少
Jpn J Med. 1985 May;24(2):109-20. doi: 10.2169/internalmedicine1962.24.109.
7
Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.伴有胆管样损伤的肝活检与明确临床诊断的对比组织学特征。
Hum Pathol. 2024 Apr;146:8-14. doi: 10.1016/j.humpath.2024.03.003. Epub 2024 Mar 11.
8
Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history.肝移植后原发性胆汁性肝硬化的复发:发病率及自然史的组织学评估
Liver Transpl. 2003 Oct;9(10):1086-93. doi: 10.1053/jlts.2003.50213.
9
Recurrent primary biliary cirrhosis.复发性原发性胆汁性肝硬化
Baillieres Best Pract Res Clin Gastroenterol. 2000 Aug;14(4):669-80. doi: 10.1053/bega.2000.0111.
10
Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.复发性原发性胆汁性肝硬化:肝移植围手术期因素及肝移植后熊去氧胆酸治疗
Liver Transpl. 2005 Oct;11(10):1252-7. doi: 10.1002/lt.20511.

引用本文的文献

1
Mechanisms governing bystander activation of T cells.T细胞旁观者激活的调控机制。
Front Immunol. 2024 Nov 27;15:1465889. doi: 10.3389/fimmu.2024.1465889. eCollection 2024.
2
Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention.成人肝移植后原发性疾病的复发——危险因素、早期诊断、管理及预防
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101432. doi: 10.1016/j.jceh.2024.101432. Epub 2024 May 22.
3
Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells.
活化记忆性 T 细胞影响初始 T 细胞命运:人类 CD8 T 细胞的非细胞毒性功能。
Commun Biol. 2022 Jun 29;5(1):634. doi: 10.1038/s42003-022-03596-2.
4
Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study.克罗地亚两个地区原发性胆汁性胆管炎的流行病学和临床特征:一项回顾性研究。
Croat Med J. 2019 Dec 31;60(6):494-502. doi: 10.3325/cmj.2019.60.494.
5
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.英国胃肠病学会/英国原发性胆汁性胆管炎治疗和管理指南。
Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.
6
Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study.女性患者肝移植后原发性胆汁性胆管炎复发的危险因素:一项日本多中心回顾性研究。
Hepatol Commun. 2017 May 16;1(5):394-405. doi: 10.1002/hep4.1037. eCollection 2017 Jul.
7
Recurrence of autoimmune liver diseases after liver transplantation.肝移植后自身免疫性肝病的复发
World J Hepatol. 2015 Dec 18;7(29):2896-905. doi: 10.4254/wjh.v7.i29.2896.
8
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects.肝移植后自身免疫性肝病的复发:临床情况
Auto Immun Highlights. 2012 Oct 30;3(3):113-8. doi: 10.1007/s13317-012-0040-5. eCollection 2012 Dec.
9
Primary biliary cirrhosis and liver transplantation.原发性胆汁性肝硬化与肝移植
Intractable Rare Dis Res. 2012 May;1(2):66-80. doi: 10.5582/irdr.2012.v1.2.66.
10
Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.趋化因子在慢性肝移植功能障碍发病机制及潜在治疗靶点中的作用
Clin Dev Immunol. 2013;2013:325318. doi: 10.1155/2013/325318. Epub 2013 Dec 8.